Treatment of hirsutism with myo-inositol: a prospective clinical study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18854115
Conclusion of this study
No significant changes were observed in serum triglyceride, apolipoprotein B and lipoprotein(a) concentrations. Insulin resistance (P < 0.01), analysed by homeostasis model assessment, was reduced significantly after therapy. Administration of oral myo-inositol significantly reduced hirsutism and hyperandrogenism and ameliorated the abnormal metabolic profile of women with hirsutism.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study